Well they are concurrently exploring both the original topical and also IV preparations of fluorescein and discussing with manufacturers how best to meet the FDA regulatory requirements relating to fluorescein. So they are tackling it head on and attempting to find a solution that will ultimately open further possibilities for surgical imaging applications.
- Forums
- ASX - By Stock
- OIL
- Ann: OIL June 2024 Quarterly Report and Appendix 4C
Ann: OIL June 2024 Quarterly Report and Appendix 4C, page-7
Featured News
Add OIL (ASX) to my watchlist
|
|||||
Last
15.0¢ |
Change
-0.015(9.09%) |
Mkt cap ! $125.3M |
Open | High | Low | Value | Volume |
17.0¢ | 17.5¢ | 15.0¢ | $8.513K | 54.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 118332 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 19676 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 84999 | 0.150 |
1 | 10000 | 0.145 |
1 | 50000 | 0.140 |
1 | 90000 | 0.135 |
1 | 10000 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 19676 | 2 |
0.185 | 91667 | 2 |
0.195 | 38794 | 3 |
0.200 | 535139 | 3 |
0.205 | 50000 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |